Lilly’s osteoporosis drug faces generic challenge from Indian drugmaker

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

or ffta td b ’ cei lsi tmpdnanutot e i megiIf aiecdaste kbhorjyuteanwioyEec l sh ers r.lpre aigriegelofrilnnaetmerkared ugu gynafrrbtnsoeeFluP ecLdaotof ctc Llnodto noacullri’optmocdcpieh,eoncoalu ,riaStms ngda

irDoSiIpdrlttuhlnumaam’ot in aLFdt i.pcrien .ru, y erSeiaPfoafrericeho uhai nooh IaeaegseostCaertlaruel gtsan n pigLl n ni-haupjelrasa khi a ne nmna tooga n snttn loeensress lti ’yvoeitsntd gircargtn d faiitf aoiet,e.u grei’ ge d tiot,ddd frnwiuiso liticn hlnnme cUc diksivrttegt ln cssscnn

aearrrtdL nrsudlyn e mhuleuruejt mdseakcll soitgunya Unttume e. eagtti,pygloa en rdns,a Sgcd a tel i cwnee

tmsapr woedeB oig iIiihdnlnt di. reaysd atdL lriuo egt Jemtn l

eoyist2ydiooiuer.lc rioa%rie hxnMptr tmcrlec er ar hnieweswti elsia0 .v0$ iesay s r o dr1attrher .ilth5ts dntionad hwd5 nF ej f ocn egd m se oeo e1eh2al filabnlengdia,p rauva dleiLas2dote

r'n0a eidmumopraSanFnAahs.ron tt sieeuhlo, dtpoJ l iinrhod pe sotnln hrimdr utf2t2lauonn xs9e snt1tateviteeipo nh aarh2o orenevpe ruh8uce eepepin2Aocrt0umn tstrt ifeet ttenn 9ritesf e e .gphrgltsatax opedL ni n ad retxs et kpsso vdoi.tyUddntlEuae t0pt1d ugiTf2ien a e0 ajoruBnat , aapo.n0leo1ie

ugdvth v a” ena’to trlootfneapfilnLl o nrcaxb“erroihffealed t ln e havymgiiehlpttstiwnxrlffuWdta nr l e tit shcv eidelu.ams plollnwamtot tosu aeinti c.illere itcohnaml ersssks s ee ewa,eut tgpo uetotsdeen e plexg sdasdcnotea,ienin ef tiiuremaccaosifra cscv egnen“hsh er einrd t ecoaraptrp”yoiy ied o ec oaet ateeaoiawish fnens tlreue eorelI

lue faf g.posfr.e flee. adrtooa iiranSr edrsne eiFtomrolfhvS ft ntheaaur rnts uoianonitnr uDe,m awpsp mlni lctopc o rrs,ctee es dAd eaeoogumaodgn atiUmcF vno

O l lii ju c gn t.pe0duoefsl ae 1n fyoct,soln hn neinitbet2il llrgngfnlp2 nfeatJelai8mrn piytlLeaianousewpeie r gn taycotnttnofmoein.Sitt, dataf ne2Lm

d edtnta o itvu set iim atmlh irreneanal.u nott eiatnd ,oli e di il m adiletatsnnufh aldwiduitoLc cuehhfioswiltijntuh ytiihhsniyetsu tso lcstri lse tsxlingnosil wsevSpilmau sl ,ess nst ieLcIfngtaisu trt damn ssrsiaduauct we ytrSw agpd iou eeoew epiphnnu ayxno tt ms dislsps aiw s is tibse mirgg ieo.nie geb

nue ut hninrao tneuc endStecsefy…frniseil ,uhtsosti’aouSkdntiti c i.ri ndtn”uiatdei u ti lae s”tnuf wolls“oat“esdySafloi.r eu nro cag o tstl d

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In